Type 2 diabetes drug linked to amputation risk
A link has been found between a type 2 diabetes drug and a higher risk of amputation, research has shown. Scientists discovered a link between the usage of NICE-recommended canagliflozin to treat ...
A link has been found between a type 2 diabetes drug and a higher risk of amputation, research has shown. Scientists discovered a link between the usage of NICE-recommended canagliflozin to treat ...
The first oral glucagon-like peptide 1 receptor agonist (GLP-1) has shown promising results in treating type 2 diabetes. Data revealed at the Keystone Symposia on New Therapeutics for Diabetes ...
Graphic images released shows how eating too much sugar can harm the body in a bid to raise awareness of type 2 diabetes. The advertising campaign, launched by Diabetes Association of ...
A low sperm count could mean a greater risk of developing type 2 diabetes, a new study has found. Men with infertility problems could also be at risk of osteoporosis researchers in Sweden said. ...
Metformin the drug commonly used to treat type 2 diabetes could help significantly reduce the risk of breast cancer. Research, carried out by the University of Copenhagen, has suggested that ...
Unfit teenage boys could be at greater risk of type 2 diabetes in later life, regardless of body weight, a study has suggested. A total of 1.5 million 18-year-old military recruits, who did not ...
A man who was “taken by surprise” at his type 2 diabetes diagnosis is now in remission after following a weight loss plan. Anupam Sharad, 37, was told he had developed the condition ...
Using a low energy formula diet (LED) for 12 weeks produces significantly greater weight loss, according to a study unveiled at the Diabetes Professional Conference. Other benefits discovered ...
Dulaglutide does not increase the risk of major cardiovascular (CV) events in people with type 2 diabetes, research has found. The meta-analysis evaluated the CV risk in people with the ...
Incidents of serious diabetic ketoacidosis (DKA) cases in people who have been taking sodium-glucose co-transporter-2 (SGLT2) have been reported where people’s blood sugar levels have not ...